What Jeff Sessions Doesn’t Understand About Medical

New Post Public Reply Private Reply Replies (2) Message Board
wowhappens28
312
What Jeff Sessions Doesn’t Understand About Medical Marijuana

https://www.ecowatch.com/sessions-medical-mar...07998.html

On Jan. 4, Attorney General Jeff Sessions rescinded the Cole memo, a 2013 document that limits federal enforcement of marijuana laws.

This opens the door for a crackdown in the nine states with legal recreational marijuana.

The Cole memo is one of two documents that prevent the U.S. Justice Department from treating marijuana as a Schedule I drug, defined as a substance with no accepted medical treatment and high potential for abuse. The other is the 2014 Rohrabacher–Farr amendment. This legislation bars the Department of Justice from spending any funds to keep states from implementing their own laws about "the use, distribution, possession or cultivation of medical marijuana."

The amendment's language needs to be reinserted into law each year—and it's currently set to expire on Jan. 18. That would leave patients in the 29 states with legal medical marijuana without their treatments and at risk of prosecution.

I have researched a number of drugs of abuse and natural products for safety and effectiveness. Just because a drug has abuse potential doesn't mean it's always bad and just because it's natural doesn't mean it's always safe. While I'm no fan of legalizing recreational marijuana use, I believe there has to be special dispensation for patients with a legitimate medical need.

Medical Marijuana Works

There are approximately 1.2 million users of medical marijuana in these 29 states. Some of the most common ailments include pain or muscle spasms, nausea and vomiting, cancer, PTSD, seizures and glaucoma.

Patients in 29 states can legally use medical marijuana

The body has a system of receptors that can be stimulated by the chemicals in marijuana, called cannabinoids. In animal studies, cannabinoids have been used to treat symptoms like harmful weight loss, vomiting, seizures and fluid pressure in the eyes.
There isn't much human research on medical marijuana, thanks to the product's illegal status and a lack of federal research funding. Large trials are nearly impossible to conduct, since products are often adulterated and the concentrations of cannabinoids vary from plant to plant.

Even so, human trials from around the world and pockets of the U.S. offer modestly strong evidence of marijuana's benefits in a number of disorders, such as intractable nausea and vomiting, chronic pain and severe muscle spasms and epilepsy.

For example, a study published in May looked at the effects of cannabadiol—an active marijuana compound that does not cause euphoric high or hallucination—on children with Dravet syndrome, a rare genetic disorder characterized by frequent, severe drug-resistant seizures. Those who took cannabadiol cut their median number of convulsive seizures per month in half, from 12 to six. These findings may be applicable to other people with hard-to-treat seizures.

I bring up this example because it uses the highest quality study design. Also, seizures are not subjective symptoms like pain or nausea that critics may be skeptical of.

When Patients Become Criminals

In my home state of Connecticut, medical marijuana is legal. Doctors are required to certify that potential medical marijuana users have a disease for which there is adequate medical evidence for marijuana's benefit. The patient then visits a licensed dispensary facility, where a pharmacists helps to select the type of product that would work best.

In such a dispensary, pharmacists know the exact amount of the active chemicals that each product contains. Unlike illegal marijuana, their products aren't contaminated with heavy metals, bacteria, fungi, herbicides or pesticides.

What if patients can no longer access these products? They will either have to go without and lose the benefits of their treatment, leading to moderately intense marijuana withdrawal symptoms, such as insomnia, chills, shakiness and stomach pain.

Or, they might try to switch to the black market, where products may be inconsistent and prosecution is possible. In so doing, they would be supporting organized crime and exposing themselves to additional dangers. I especially worry about children with epilepsy who might have to use illegal marijuana that gives them a high due to the tetrahydrocannabinol (THC) rather than a legal version with little to no THC.

A Balanced Approach

Since 2014, the Rohrabacher-Farr amendment has been routinely included in the appropriations language with support from both parties. But in the past year, things have broken down. So far, the amendment has survived through resolutions to extend government spending, but it's unclear whether it will appear in the new federal budget.

Sessions has already written to members of Congress asking them not to support this amendment, saying it inhibits the department's authority. A new subcommittee at the Department of Justice plans to assess the legalized use of marijuana.

Legal recreational marijuana comes with potential benefits and drawbacks to society, and I'm not sure yet that we know what the impact will be over the long term. But the research on medical marijuana is clear: Marijuana has legitimate medical uses. It should not be a Schedule I drug and should not be denied to patients. There's virtually no upside to banning a potentially effective therapy for patients with diseases like cancer, multiple sclerosis and epilepsy.

Reposted with permission from our media associate The Conversation.

RELATED ARTICLES AROUND THE WEB
Legal Marijuana Is Supported by Every Group in America Except Jeff ... ›
New Analysis Shows Federal Marijuana Legalization Could Raise ... ›
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 370

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 326

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 243

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 209

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 367

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 0

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 231

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading

Top 5 Most Recently Viewed Articles

Black Hills Corp Celebrates 55 Years of Dividend Increases

Updated Category News Views 210

Black Hills Corp's Remarkable Dividend Achievement Black Hills Corp (NYSE: BKH), a utility company with a significant presence in the energy sector, has achieved a remarkable milestone by raising its quarterly dividend for the 55th consecutive year. This latest increase brings the dividend to $0.676 per share, up from the previous $0.65. This change reflects the...

Continue Reading
Koala Eco and Whole Foods Team Up for Sustainable Care

Updated Category News Views 292

Koala Eco Launches at Whole Foods Market Whole Foods Market is proud to welcome Koala Eco, a brand dedicated to creating sustainable home and self-care products powered by the essence of Australian essential oils. This new partnership is designed to amplify eco-conscious living while providing effective solutions for your body, home, and mind. About Koala Eco and Its...

Continue Reading
Chelsea Lighting Earns Top Recognition in New York Business List

Updated Category News Views 71

Chelsea Lighting Named One of the Best Places to Work in 2024 Chelsea Lighting is excited to announce its inclusion in Crain’s New York Business list of the Best Places to Work for 2024, a recognition it has achieved for three years in a row. This honor highlights the company’s outstanding workplace culture. As a well-respected distributor of value-add lighting...

Continue Reading
AstraZeneca Investors Invited to Take Action Against Losses

Updated Category News Views 144

Investors Encouraged to Act Amid Legal Uncertainties AstraZeneca PLC, known in the biopharmaceutical sector, has caught the attention of investors recently due to legal complications that may significantly affect its stock value. Individuals who acquired AstraZeneca equities during a specific timeframe may now have a chance to lead a class action lawsuit. This opportunity...

Continue Reading
WELL Health and HEALWELL AI to Revolutionize Clinical Trials

Updated Category News Views 223

WELL Health and HEALWELL AI to Revolutionize Clinical Trials WELL Health and HEALWELL AI are excited to announce a significant expansion of their strategic alliance. This multi-year agreement is set to transform clinical trials by enabling management and development at WELL Health clinic locations across the country. With HEALWELL's expertise as a Contract Research...

Continue Reading